Branding a new spinal procedure.
With Vertiflex receiving FDA approval on its Superion product and minimally-invasive procedure for treating lumbar spinal stenosis, ParkerWhite was tasked with helping the team build a new brand positioning strategy for the company and its products. The unique Vertiflex procedure was groundbreaking for patients and offered a new treatment option for pain management physicians with a non-opioid pain management solution that can help improve the lives of the growing number of patients suffering from chronic pain.
What we did:
Creative Collateral Systems
Digital Strategy & Creative
The Brand Strategy
Building on their successful clinical trial, we built a brand messaging platform that established an authentic and credible set of core values which underlined their mission and passion to help millions of patients suffering from chronic back pain.
We developed a new website with a physician locator and patient education, and developed sales tools to reflect a company focused on product innovation and patient empathy, to connect with spinal physicians, patients, and the investment community.
Since the launch of the new brand, Vertiflex has seen incredible growth over the last few years with incredible patient success stories on how the procedure has changed their lives. This success gained the attention of Boston Scientific who purchased the company in June of 2019 for over $465M.
From strategy to execution.
We partner with our clients to understand their business, people, and goals to provide practical solutions that deliver long-term success.